OOIR: Observatory of International Research

Papers

(The H4-Index of Journal of Neurology is 42. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-10-01 to 2025-10-01.)

Article	Citations
Prevalence of infratentorial superficial siderosis in a large general population sample from the UK Biobank	127
The deltoid muscle and the pattern of paresis in ALS	126
A role for the Epstein–Barr virus in multiple sclerosis aetiology?	118
Pallidal deep brain stimulation for patients with myoclonus-dystonia without SGCE mutations	111
Richard Caton (1842-1926)	111
Microstructural characterization of multiple sclerosis lesion phenotypes using multiparametric longitudinal analysis	99
Neuromyelitis optica spectrum disorder with a familial Mediterranean fever gene E84K mutation	96
Tacrolimus-induced Parkinsonism	96
Interpretable deep learning survival predictions in sporadic Creutzfeldt–Jakob disease	92
Different patterns of acute saccadic response to levodopa in de novo Parkinson’s disease	78
Reversible cerebral vasoconstriction syndrome after intravenous iron substitution: a case report	69
Brain 18F-FDG PET findings and sequential vestibular testing in SCA27B: a case report	67
Neurological manifestation of HEV infection: still a rare disease entity?	67
Halting progressive multifocal leukoencephalopathy with pembrolizumab: the case of a patient with multiple sclerosis under fingolimod	65
The DeMyers: Marian (1922–2012) and William (1924–2008)	62
Risk of secondary progression in patients with highly active multiple sclerosis treated with natalizumab: a real-life study	62
Tourette syndrome: effects of acetyl-leucine in two individuals	61
Restless legs syndrome in Parkinson’s disease: epidemiology, pathogenetic overlaps, and clinical management	60
Response to SARS-CoV-2 vaccination in multiple sclerosis patients on disease modifying therapies	59
Epileptic disorders in Becker and Duchenne muscular dystrophies: a systematic review and meta-analysis	59
Primary progressive aphasia: six questions in search of an answer	59
Eye tracking identifies biomarkers in α-synucleinopathies versus progressive supranuclear palsy	57
Explaining recovery from coma with multimodal neuroimaging	57
Long-term efficacy and safety of ravulizumab in adults with anti-acetylcholine receptor antibody-positive generalized myasthenia gravis: results from the phase 3 CHAMPION MG open-label extension	56
Analysis of C9orf72 repeat length in progressive supranuclear palsy, corticobasal syndrome, corticobasal degeneration, and atypical parkinsonism	54

Increased aneurysm wall permeability colocalized with low wall shear stress in unruptured saccular intracranial aneurysm	54
Prevalence of hereditary transthyretin amyloidosis in CIDP patients with red flags: a multicenter genetic screening and misdiagnosis analysis	53
Incidence of Guillain–Barré syndrome in Cuba before and during the Oropouche virus emergency, 2018–2024	51
Historical and current issues in HIV encephalitis, and the role of neuropathology in HIV disease: a pathological perspective	50
Brain network topology and future development of freezing of gait in Parkinson’s disease: a longitudinal study	49
Dopaminergic responsiveness and dopaminergic challenge tests of Parkinson’s disease: a systematic review and meta-analysis	49
Phenotype-driven reanalysis reveals five novel pathogenic variants in 40 exome-negative families with Charcot–Marie–Tooth Disease	49
Humoral response after accelerated schedule of HBV vaccination in MS patients before anti-CD20 therapy	48
Sensory neuropathy due to RFC1 in a patient with ALS: more than a coincidence?	48
Correction to: Epilepsy related multimorbidity, polypharmacy and risks in adults with intellectual disabilities: a national study	48
Hashimoto’s encephalopathy with diffuse leukoencephalopathy: serial MRI and gait analysis	48
A decision aid is not the quick fix for improving shared decision-making in advanced Parkinson’s disease: results of a mixed methods feasibility study	47
Exploring epigenetic modifications as potential biomarkers and therapeutic targets in amyotrophic lateral sclerosis	46
Stroke frequency, associated factors, and clinical features in primary systemic vasculitis: a multicentric observational study	46
Correction to: Synergistic effects of vagus nerve stimulation and antiseizure medication	45
Keeping an eye on Parkinson’s disease: color vision and outer retinal thickness as simple and non-invasive biomarkers	44
Long-term outcome after decompressive hemicraniectomy for malignant middle cerebral artery infarction	44
Dystonia management across Europe within ERN-RND: current state and future challenges	42
A retrospective study of autoimmune cerebellar ataxia over a 20-year period in a single institution	42